Skip to Content
Søk Menu
Välkommen till lungcancer

Få de senaste artiklarna och MEDtalks om lungcancer.

Senaste nytt om lung cancer

Jens Benn’s Encounter with Heine Was Pivotal in His Choice of Lung Oncology

  • / Jens Benn Sørensen / Amanda Feldballe Bernholm

Swedish and Nordic Lung Cancer Insights – October Update

/ Jan Andreasen / Amanda Feldballe Bernholm
Lung cancer-highlightsLungcancer

Lung Cancer Insights: What’s New in the Field – October Update

/ Jan Andreasen / Amanda Feldballe Bernholm
Lung cancer-highlightsLungcancer
Katharina Leuchte

ESMO 2025: High-Intensity Interval Training Promotes Immune Responses in mNSCLC Patients

/ Katharina Leuchte
ESMO25Lungcancer Play the Video
Pasi Jänne

New Class of Medicines Emerge as Potential Therapies in MTAP-Deleted NSCLC

/ Pasi Jänne
LungcancerNSCLCWCLC25 Play the Video

Lung Cancer highlights

Lung Cancer Insights: What’s New in the Field

/ Jan Andreasen / Amanda Feldballe Bernholm
Lung cancer-highlightsLungcancer

MEDtalks

Michael Stenger

WCLC 2025: Lung Cancer Screening and Early Results from the Danish PLUS Trial

/ Michael Stenger
LungcancerWCLC25 Play the Video
Maria Silvoniemi

Clinical Dilemmas in the Management of NSCLC Without Driver Mutations

/ Maria Silvoniemi
LungcancerNSCLC Play the Video
Luis Paz-Ares

ASCO 2025: Lurbinectedin–Atezolizumab Improves Survival in SCLC

/ Luis Paz-Ares
ASCO25Lungcancer Play the Video
Miriam Grønberg

Treatment Timing Impacts Survival in Limited Stage Small Cell Lung Cancer

/ Miriam Grønberg
Lungcancer Play the Video
Karin Lindberg

Kliniska fördelar med stereotaktisk strålbehandling vid oligometastatisk non-small cell lungcancer, NSCLC

/ Karin Lindberg
LungcancerOnkologisk Forum 2024 Play the Video

Outstanding Results for the Treatment of Lung Cancer

/ Tony Mok
Lungcancer Play the Video
Load more

Artiklar

New Data Support Osimertinib as a Backbone Treatment for EGFRm Advanced NSCLC

/ Jan Andreasen
LungcancerNSCLCWCLC25

Amivantamab + Lazertinib in EGFR-Mutated Advanced NSCLC: PALOMA-2 Update

/ Jan Andreasen
LungcancerNSCLCWCLC25

Första linjens NSCLC utan cancerdrivande mutationer: praktik, brister och kostnader

/ Ronny Öhman / Jan Andreasen
LungcancerNSCLC

New Treatment Possibilities Improve Future Outcomes of Lung Cancer

/ BestPractice Nordic
ESMO24Lungcancer

No Major Breakthroughs in Lung Cancer Compared to ESMO 2023

/ BestPractice Nordic
ESMO24Lungcancer

CheckMate 227: 6-year data on the treatment of locally advanced NSCLC with Opdivo and Yervoy  

/ BestPractice Nordic
LungcancerNSCLCWCLC23
Back to top